Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Madopar versus sinemet. A clinical study on their effectiveness.

J J Korten, A Keyser, E M Joosten

    European Neurology
    |January 1, 1975
    PubMed
    Summary

    Madopar and Sinemet showed equal effects in Parkinson

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Comparing owner reported and genetic breed identification reveals high concordance in a large cohort from the Dog Aging Project.

    Scientific reports·2025
    Same author

    [Anesthesia management in implantation of baroreceptor stimulators].

    Der Anaesthesist·2015
    Same author

    Anthropological neurology: symptoms and their meanings according to Joseph Prick (1909-1978).

    Journal of the history of the neurosciences·2011
    Same author

    Cardiac resynchronization therapy in patients with absent right but persistent left superior vena cava.

    The Thoracic and cardiovascular surgeon·2009
    Same author

    [Not Available].

    Herzschrittmachertherapie & Elektrophysiologie·2009
    Same author

    Pharmacotherapy of epilepsy: state of the art and developments.

    Journal of clinical pharmacy and therapeutics·2009

    Area of Science:

    • Neurology
    • Pharmacology

    Background:

    • Parkinson's disease (PD) management often involves levodopa-based medications.
    • Madopar and Sinemet are common formulations containing levodopa.

    Purpose of the Study:

    • To compare the efficacy and side effects of Madopar and Sinemet in Parkinson's disease patients.
    • To assess the impact of switching between these two levodopa formulations.

    Main Methods:

    • A cohort of 15 Parkinson's disease patients were switched from Madopar to Sinemet.
    • Treatment duration was 3 months.
    • Objective test procedures were used for outcome measurement and comparison.

    Main Results:

    • Madopar and Sinemet demonstrated equivalent therapeutic effects when administered at the same levodopa dosage.
    • One patient discontinued Sinemet due to ventricular extrasystoles.
    • The study noted the occurrence of involuntary hyperkinesias and the on-off effect.

    Conclusions:

    • Madopar and Sinemet are interchangeable for Parkinson's disease treatment, provided levodopa dosage is equivalent.
    • Careful monitoring for cardiac side effects like ventricular extrasystoles is warranted.
    • Further attention to hyperkinesias and the on-off phenomenon is relevant in clinical practice.

    Related Experiment Videos